MYF5 |
MYF5: Myogenic factor 5 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
78.260 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
CSK |
CSK: Tyrosine-protein kinase CSK |
78.230 |
Evidence |
O
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
78.230 |
Evidence |
O
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
77.910 |
Evidence |
O
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
77.560 |
Evidence |
O
|
COL1A1 |
COL1A1: Collagen alpha-1(I) chain precursor |
MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
77.560 |
Evidence |
O
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
75.850 |
Evidence |
O
|
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
74.960 |
Evidence |
O
|
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
JUNB |
JUNB: Transcription factor jun-B |
73.630 |
Evidence |
O
|
JUN |
JUN: Transcription factor AP-1 |
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
73.630 |
Evidence |
O
|
F10 |
F10: Coagulation factor X precursor |
PLG |
PLG: Plasminogen precursor |
73.260 |
Evidence |
O
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
72.770 |
Evidence |
O
|
TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
TAF2 |
TAF2, CIF150, TAF2B: Transcription initiation factor TFIID subunit 2 |
70.890 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
69.950 |
Evidence |
O
|
EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
EIF2S3 |
EIF2S3, EIF2G: Eukaryotic translation initiation factor 2 subunit 3 |
69.740 |
Evidence |
O
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
68.930 |
Evidence |
O
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
68.930 |
Evidence |
O
|
DSTN |
DSTN, ACTDP, DSN: Destrin |
ACTB |
ACTG1, ACTB, ACTG: Actin, cytoplasmic 2 |
67.190 |
Evidence |
O
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
67.060 |
Evidence |
O
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
67.060 |
Evidence |
O
|
RPLP1 |
RPLP1, RRP1: 60S acidic ribosomal protein P1 |
RPLP0 |
RPLP0: 60S acidic ribosomal protein P0 |
64.520 |
Evidence |
O
|
POLR2C |
POLR2C, A-152E5.7: DNA-directed RNA polymerase II subunit RPB3 |
POLR2B |
POLR2B: DNA-directed RNA polymerase II subunit RPB2 |
64.260 |
Evidence |
O
|
CCT4 |
CCT4, CCTD, SRB: T-complex protein 1 subunit delta |
CCT2 |
CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta |
63.180 |
Evidence |
O
|
EEF2 |
EEF2, EF2: Elongation factor 2 |
EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
63.180 |
Evidence |
O
|
PCNA |
PCNA: Proliferating cell nuclear antigen |
LIG1 |
LIG1: DNA ligase 1 |
63.180 |
Evidence |
O
|